WASHINGTON
,
June 17, 2022
(press release)
–
The U.S. Food and Drug Administration on Friday authorized emergency use of two COVID-19 vaccines for children under 5, moving the country one step closer to having shots for all age groups. The decision leaves just one hurdle, a recommendation from the Centers for Disease Control and Prevention, before parents can begin getting babies and toddlers vaccinated against the virus. That CDC decision is expected this weekend. “As we have seen with older age groups, we expect that the vaccines for younger children will provide protection from the most severe outcomes of COVID-19, such as hospitalization and death,” FDA Commissioner Robert M. Califf said in a statement. “Those trusted with the care of children can have confidence in the safety and effectiveness of these COVID-19 vaccines and can be assured that the agency was thorough in its evaluation of the data.” The FDA’s decision to grant emergency use requests for a two-dose Moderna shot and a three-dose Pfizer vaccine came two days after its outside panel of advisers unanimously voted on Wednesday to recommend use of the two vaccines. White House COVID-19 Response Coordinator Ashish Jha said earlier this month that the federal government would begin shipping the vaccines to states as soon as the FDA granted the emergency use authorization. He expects shots can begin next week as long as the CDC issues its recommendation over the weekend. The Biden administration made 10 million doses of vaccine for kids under 5 available for states during a two-week pre-ordering period that closed Tuesday. States, tribes, territories, pharmacies and other federal partners ordered 2.5 million Pfizer doses, about 50% of those available, and 1.3 million Moderna doses, about 25%, according to a spokesperson for the U.S. Department of Health and Human Services. “Jurisdictions will have an opportunity to order additional doses if and when the vaccines are authorized by FDA and recommended by CDC,” an HHS spokesperson said in a statement. Florida vaccination distribution in question White House press secretary Karine Jean-Pierre said Thursday that some pharmacies and community health centers in the state would have COVID-19 vaccines for kids under 5 through federal distribution. But those options are limited for parents wishing to vaccinate their kids, she said. “By being the only state, this is Florida, not pre-ordering … pediatricians, for example, in Florida will not have immediate ready access to vaccines,” Jean-Pierre said. “Some pharmacies and community health centers in the state get access through federal distribution channels, but those options are limited for parents. We encouraged Florida on several occasions to order vaccines. We’ve been aware of this, and we will continue to do so.” Florida not pre-ordering, Jean-Pierre said, will “make it harder” for parents to get their children vaccinated. “That’s why we continued to, on several occasions, encourage Florida to do this,” she said. The Florida Department of Health said in a statement Thursday that its officials have “made it clear to the federal government that states do not need to be involved in the convoluted vaccine distribution process, especially when the federal government has a track record of developing inconsistent and unsustainable COVID-19 policies.” “Doctors can order vaccines if they are in need, and there are currently no orders in the Department’s ordering system for the COVID-19 vaccine for this age group,” the statement continued. Florida Gov. Ron DeSantis said Thursday that “there’s not going to be any state programs,” to vaccinate babies and toddlers against COVID-19. “That’s not something that we think is appropriate and so that’s not what we’re going to be utilizing our resources in that regard,” DeSantis said.
Florida remains the only state not to have placed any pre-orders.
The views expressed in content distributed by Newstex and its re-distributors (collectively, "Newstex Authoritative Content") are solely those of the respective author(s) and not necessarily the views of Newstex et al. It is provided as general information only on an "AS IS" basis, without warranties and conferring no rights, which should not be relied upon as professional advice. Newstex et al. make no claims, promises or guarantees regarding its accuracy or completeness, nor as to the quality of the opinions and commentary contained therein.
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.
